在细胞癌中,表观遗传沉默的KAT2B通过破坏HDAC5/LSD1复合体组合来抑制de novo脂质生成
Qi Wang1, Daojia Miao1, Ruijie Liu1
1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China; Institute of Urology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Journal of advanced research
|August 10, 2025
概括
氨酸乙烯转移酶2B (KAT2B) 通过抑制脂肪酸合成酶 (FASN) 抑制细胞癌 (RCC) 中的脂质积累. 低KAT2B表达预测预后不佳,这表明FASN抑制剂是RCC的潜在治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 细胞癌 (RCC) 提出了治疗耐药性的挑战.
- 不调节的脂质代谢是RCC的一个关键特征和潜在的治疗点.
研究的目的:
- 调查脂质代谢在RCC中的作用.
- 为了确定RCC治疗的新型治疗点.
主要方法:
- 生物信息学分析以确定枢纽基因.
- 基因表达分析 (qRT-PCR,西部斑块,IHC).
- 功能测定 (CCK-8,Transwell),脂管学,Co-IP,免疫光,以及体内/器官模型.
主要成果:
- 氨酸乙转移酶2B (KAT2B) 被确定为一种与脂质相关的生物标志物,其低表达与RCC预后不佳有关.
- 减少KAT2B的表达是由于促进剂高甲基化.
- 通过通过HDAC5.5.的乙化抑制脂肪酸合成酶 (FASN) 表达的抑制,KAT2B抑制了de novo脂质生成.
- 失去KAT2B促进脂质积累和RCC进展;FASN抑制减轻了这些影响.
结论:
- KAT2B通过破坏HDAC5-LSD1复合体来抑制脂质生成.
- 在RCC中,KAT2B是一种瘤抑制剂.
- FASN 抑制剂对具有低KAT2B表达的RCC患者来说是一个潜在的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K


